Neraminol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C20H26N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H5HKR8OEF3, chemically known as (- )-1-(1h-indazol-4-yloxy)-3-((2-(2,6-xylidino)ethyl)amino)-2-propanol but generally known as neraminol, which bears US NIH Compound Identifier 3047789. European Medicines Agency schedules Neraminol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09203MIG. The term NERAMINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). NERAMINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule neraminol under HS 29339990 and SITC 51577. As of Q4 2014, NERAMINOL remains the US FDA Preferred Term for this commodity. Neraminol bears US NLM identifiers UMLS ID C2698450 and NCI Concept Code C76552. SMILES: O(CC(O)CNCCNC1C(CCCC1C)C)C1C2C([NH]NC2)CCC1.